Rachel A. Burga

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases

Steven C. Katz, Rachel A. Burga, Elise McCormack et al. · Clinical Cancer Research · 2015 · 371 citations

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T

Rachel A. Burga, Mitchell Thorn, Gary R. Point et al. · Cancer Immunology Immunotherapy · 2015 · 212 citations · Full text

Cancer Immunosurveillance, Hepatocellular Carcinoma, Liver Physiology +9

A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration

Nora T. Khanarian, Nora M. Haney, Rachel A. Burga et al. · Biomaterials · 2012 · 153 citations · Full text

Tissue Engineering, Regenerative Medicine, Synthetic Bone Substitute +8

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma

Juliana Cano‐Mejia, Rachel A. Burga, Elizabeth E. Sweeney et al. · Nanomedicine Nanotechnology Biology and Medicine · 2016 · 144 citations · Full text

Nanomedicine, Checkpoint Inhibition, Engineering +10

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma

Eric Yvon, Rachel A. Burga, Allison B. Powell et al. · Cytotherapy · 2017 · 126 citations

Neuro-oncology, Cell Therapy, Cancer Immunosurveillance +11